6 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Best EScalation Treatment in Multiple Sclerosis (MS) (BEST MS)
Date du début: 1 nov. 2012, Date de fin: 31 oct. 2016,
"Multiple Sclerosis (MS) is a devastating disease of the central nervous system affecting 2.5 million worldwide. MS is a field of constant therapeutic innovation, a fact which brings hope to young adults since MS is one of the most frequent causes of severe handicap. A major unmet need is to rationalize treatment decisions. To date, there is no way of predicting which patients will best respond to ...
Voir le projet
5
Participants partenaires
TERMINÉ
Identifying correlates of protection to accelerate vaccine trials: systems evaluation of two models of experimentally-induced immunity to malaria (SysMalVac)
Date du début: 1 janv. 2013, Date de fin: 31 déc. 2014,
Vaccine development is an empirical process (trial and error) and involves a long, expensive clinical development pipeline to license an efficacious vaccine candidate. Better tools for vaccine evaluation are needed to adapt to a rising number of candidate vaccines entering clinical trials for many diseases. Surrogate biomarkers of immunity offer the possibility of expediting the clinical developme ...
Voir le projet
8
Participants partenaires
TERMINÉ
A new generation of fibre-based diagnostic sensors (BiognostiX)
Date du début: 1 avr. 2011, Date de fin: 31 mars 2014,
The BiognostiX project will develop technologies and flexible manufacturing methods for the fabrication of inexpensive biodiagnostic sensors on fibre-based substrates (e.g. paper or card).Fabrication will be based on fluid-jet techniques, allowing the sensor platforms to be reconfigurable (customisable) at the point of manufacture to perform different biodiagnostic test functions including quantit ...
Voir le projet
6
Participants partenaires
TERMINÉ
Collaborative European effort to Develop Diabetes Diagnostics (CEED3)
Date du début: 1 déc. 2008, Date de fin: 30 nov. 2012,
"CEED3 (Collaborative European Effort to Develop Diabetes Diagnostics) has as its central objective, the development of diagnostic tools to differentiate specific subgroups of diabetic patients to allow individualisation of patient care. CEED3 will achieve this by integrating basic science findings from animal models, cell studies, and large scale genetic studies with clinical observations and tes ...
Voir le projet
12
Participants partenaires
TERMINÉ
United Europeans for the Development of Pharmacogenomics in Multiple Sclerosis (UEPHA-MS)
Date du début: 15 sept. 2008, Date de fin: 14 sept. 2012,
"Multiple sclerosis (MS) is a chronic inflammatory, disabling disease of the central nervous system. Recent studies suggest that over the last 50 years a disproportional increase in incidence of MS in women has taken place. The lifetime costs of MS exceed 1.5 million € per case in the UK, and are likely to be similar in other European countries. There is no definitive cure for MS. Immunomodulatory ...
Voir le projet
12
Participants partenaires
TERMINÉ
Mucosal protease and their inhibitors in inflammatory bowel disease: From etiopathogenetic insight to innovative therapy (IBDase)
Date du début: 1 mars 2008, Date de fin: 31 mai 2011,
IBDase addresses the etiology and pathogenesis of inflammatory bowel disease (IBD) with a multidisciplinary plan for innovative diagnosis and therapy focused on mucosal proteases and their inhibitors (P/PIs). The incidence of IBD, a multifactorial disease influenced by environmental factors in a background of complex genetic susceptibility, is rising, particularly among European children. Current ...
Voir le projet